Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02356159
Title Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

lymphoma

acute lymphoblastic leukemia

acute myeloid leukemia

multiple myeloma

Therapies

Cytarabine + Fludarabine

Palifermin

Prednisone

Filgrastim

Methotrexate + Sirolimus + Tacrolimus

Doxorubicin + Etoposide + Fludarabine + Vincristine Sulfate

Cyclophosphamide + Fludarabine

Rituximab

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
National Institutes of Health Clinical Center Recruiting Bethesda Maryland 20892 United States Details
National Marrow Donor Program Recruiting Minneapolis Minnesota 55401 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field